Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery

Completed · Not applicable

Conditions studied: Coronary Artery Bypass Grafting

In brief

A prospective randomized open-label study that will evaluate the effectiveness of the pliable and absorbable bone hemostats (BoneSeal®) on the reduction of bleeding from the sternal bone marrow in patients undergoing cardiothoracic surgery.

Key facts

Study ID

NCT03085017

Run by

Loma Linda University

People needed

57

Starts

2017-06-07

Expected to finish

2017-11-28

Last updated by the study team

2021-06-08

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Consent given by patient prior to surgery
• Adult patients over 45 years
• Subjects requiring elective, prescheduled or urgent open heart surgery requiring a sternotomy including, but not limited to CABG, valve repair, valve replacement

You may not qualify if…

• An immune system disorder
• Known hypersensitivity to components in BoneSeal® or Ostene®
• Patients undergoing emergency surgery
• Patients undergoing aortic dissection
• No consent given

Where it is running

• Loma Linda Medical Center — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.